Mediterranean-style eating
Quick answer. Mediterranean-style eating centers on vegetables, fruit, beans, whole grains, nuts, fish and olive oil, with little processed food. In trials it helps people lose weight, though low-carb diets did a little better in the short term. The Atlas found no trial of this style in people taking GLP-1 medicines, and expert groups mainly point to it as a food-quality approach rather than a weight-loss trick.
What it is
There is no single official recipe. Mediterranean-style eating is a pattern based on traditional food in countries around the Mediterranean Sea. Most versions lean on vegetables, fruit, legumes such as beans and lentils, whole grains, nuts and seeds, fish, and olive oil as the main fat. Red meat, sweets and heavily processed foods are limited.
It is different from keto and fasting in an important way. It does not cut a food group or a time window. It changes what the plate looks like, which is why it is often described as easier to keep up. Whether that is true for most people is a question the trials only partly answer.
On a GLP-1 medicine, appetite is lower, so each meal has to count. A pattern built on fiber-rich plants, fish and olive oil is a natural fit for that idea. That is a reasonable guess, and it is not the same as a tested result.
What trials show
A 2024 network meta-analysis pooled 7 randomized trials with 1,004 adults who had overweight or obesity. Every diet it studied led to weight loss. Low-carbohydrate eating beat the Mediterranean pattern by an average of 2.7 kg (95% confidence interval 0.75 to 4.65 kg). The authors ranked low-carb first for weight and body fat, and noted that results may vary with age, sex and lifestyle.
A 2026 meta-analysis compared ketogenic and Mediterranean diets head to head in randomized trials. The ketogenic diets produced more weight loss, an average of 3.56 kg more (95% confidence interval 1.49 to 5.62 kg), along with a larger drop in waist size and body fat. Fasting blood sugar, HbA1c, LDL cholesterol, HDL cholesterol, triglycerides, blood pressure and a marker of inflammation did not differ significantly between the two. The authors suggest the Mediterranean diet may be a more sustainable choice for long-term heart and metabolic health, which is their interpretation rather than something the trials measured directly.
Weight is not the only outcome people care about. A 2025 review of 133 randomized trials looked at how well blood vessels widen, a marker of vessel health. The Mediterranean diet improved it by an average of 2.32 percentage points (95% confidence interval 1.86 to 2.78). The authors rated the certainty of the evidence as moderate to low across the review, and many trials had some risk of bias.
The Atlas did not find a randomized trial of Mediterranean-style eating in people taking semaglutide or tirzepatide. A 2026 review of plant-based strategies for obesity says the strongest trial evidence supports polyphenol-rich patterns, particularly a version called the green Mediterranean diet, for body weight and visceral fat. The same review calls for future trials that test these approaches alongside GLP-1 medicines.
What experts say about it with a GLP-1 medicine
The 2025 advisory from four U.S. nutrition and obesity societies does not tell people to follow one named diet. It says many dietary patterns have been used with success, and that sticking with the pattern and attending counseling visits are often the factors that decide results. It recommends minimally processed, nutrient-dense foods, which describes most Mediterranean-style meals.
The advisory also mentions that mixed meals higher in protein or fiber, and patterns such as the Mediterranean diet, may increase the body's own GLP-1 release. It describes this as something that still needs investigation, so it is not a reason to expect a boost on top of the medicine.
Practical steps from the advisory that fit this style well: build meals around protein and fiber, drink enough fluid, and ask for a registered dietitian visit when eating becomes difficult. The protein page and constipation page cover those topics.
What people report
In online communities of people on GLP-1 medicines, Mediterranean-style eating comes up as the plan people turn to when they want something less strict than keto. The themes people commonly describe are that it is easier to follow at restaurants and family meals, that fish, beans and vegetables sit more comfortably than greasy food, and that the fiber helps with constipation.
People also commonly mention the hard parts. With a small appetite, a plant-heavy plate can fill you up before you reach your protein target, and olive oil and nuts add calories that are easy to overlook. Many describe adding eggs, Greek yogurt, fish or beans to make sure protein keeps up.
None of this was measured. People who like the pattern are more likely to post about it, and nobody checks what they actually ate. It is here because many people say this style helps them stay consistent, not because it proves anything.
Who needs to be careful
- Anyone with kidney disease, who may need limits on potassium, phosphorus or protein that change what a healthy plate looks like.
- Anyone with fish, nut or other food allergies, or on a blood thinner such as warfarin, where large changes in leafy green vegetables matter.
- Anyone whose appetite is very low, since a bulky plant-heavy diet can crowd out protein.
Questions to bring to a clinician or dietitian
- Does a Mediterranean-style plan fit my health history and my other medicines?
- How much protein should I aim for if I eat mostly plants and fish?
- Should I limit nuts and olive oil if my weight loss slows?
- Can a registered dietitian help me plan meals around my dose schedule?
What is still unknown
- Whether Mediterranean-style eating adds anything to a GLP-1 medicine is untested.
- How it compares with other diets over several years in people on these medicines is unknown.
- Whether any of the food-based effects on the body's own GLP-1 release matter alongside a medicine is unknown.
Related pages
Sources
- Comparison of weight loss effects among overweight/obese adults: a network meta-analysis of Mediterranean, low carbohydrate, and low-fat diets Akbari M, et al. Clin Nutr ESPEN. 2024;64:7-15. PMID 39255914. Funding: Not stated in the abstract. Journal article
- Comparative effects of ketogenic diets and Mediterranean diets on obesity and metabolic outcomes: a systematic review and meta-analysis Kun X, et al. Rev Endocr Metab Disord. 2026. PMID 42766067. Funding: Not stated in the abstract. Journal article
- The effects of whole foods and dietary patterns on flow-mediated dilation: a systematic review and meta-analysis of randomized controlled trials Trinquet NM, et al. Am J Clin Nutr. 2025;122(5):1204-1232. PMID 40972869. Funding: Not stated in the abstract. Journal article
- Beyond GLP-1 agonists: plant-derived bioactive compounds as adjunctive strategies for obesity management Vasile A, et al. Nutrients. 2026;18(14). PMID 42514335. Funding: Not stated in the abstract. Journal article
- Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society Mozaffarian D, et al. Obes Pillars. 2025;15:100181. PMID 40673264. Funding: Professional societies; several authors report industry relationships. Journal article